These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17620054)

  • 61. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
    Black DM; Schwartz AV; Ensrud KE; Cauley JA; Levis S; Quandt SA; Satterfield S; Wallace RB; Bauer DC; Palermo L; Wehren LE; Lombardi A; Santora AC; Cummings SR;
    JAMA; 2006 Dec; 296(24):2927-38. PubMed ID: 17190893
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A cohort study of the effect of endogenous estrogen on spine fracture risk and bone structure in elderly women and an assessment of its diagnostic usefulness.
    Prince RL; Dick IM; Beilby J; Dhaliwal SS; Devine A
    Bone; 2007 Jul; 41(1):33-8. PubMed ID: 17482901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of the effect of estradiol on biochemical bone turnover markers among postmenopausal women.
    Jamka K; Adamczuk P; Skowrońska A; Bojar I; Raszewski G
    Ann Agric Environ Med; 2021 Jun; 28(2):326-330. PubMed ID: 34184518
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life.
    Sugiya N; Nakashima A; Takasugi N; Kawai A; Kiribayashi K; Tanaka J; Kohno N; Yorioka N
    Osteoporos Int; 2011 May; 22(5):1573-9. PubMed ID: 20652228
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group.
    Weiss SR; Ellman H; Dolker M
    Obstet Gynecol; 1999 Sep; 94(3):330-6. PubMed ID: 10472854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency.
    Zirilli L; Maffei L; Meunier PJ; Chavassieux P; Carani C; Rochira V
    Bone; 2009 Nov; 45(5):827-32. PubMed ID: 19345749
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in bone density and turnover after alendronate or estrogen withdrawal.
    Wasnich RD; Bagger YZ; Hosking DJ; McClung MR; Wu M; Mantz AM; Yates JJ; Ross PD; Alexandersen P; Ravn P; Christiansen C; Santora AC;
    Menopause; 2004; 11(6 Pt 1):622-30. PubMed ID: 15545790
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study.
    Välimäki MJ; Laitinen KA; Tähtelä RK; Hirvonen EJ; Risteli JP
    Am J Obstet Gynecol; 2003 Nov; 189(5):1213-20. PubMed ID: 14634543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.
    Watts NB; Nolan JC; Brennan JJ; Yang HM;
    Menopause; 2000; 7(6):375-82. PubMed ID: 11127759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G; Hansen A; Prestwood KM
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women.
    Al-Shoha A; Rao DS; Schilling J; Peterson E; Mandel S
    Spine (Phila Pa 1976); 2012 Dec; 37(25):E1567-71. PubMed ID: 23196966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):739-50. PubMed ID: 11422108
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
    Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
    Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women.
    Notelovitz M; John VA; Good WR
    Menopause; 2002; 9(5):343-53. PubMed ID: 12218723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of smoking cessation on bone mineral density in postmenopausal women.
    Oncken C; Prestwood K; Kleppinger A; Wang Y; Cooney J; Raisz L
    J Womens Health (Larchmt); 2006 Dec; 15(10):1141-50. PubMed ID: 17199455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.